Ardent Health Partners, LLC (ARDT)
Automate Your Wheel Strategy on ARDT
With Tiblio's Option Bot, you can configure your own wheel strategy including ARDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ARDT
- Rev/Share 44.9995
- Book/Share 11.6088
- PB 1.0274
- Debt/Equity 1.8378
- CurrentRatio 2.0754
- ROIC 0.1612
- MktCap 1295848504.0
- FreeCF/Share 1.1019
- PFCF 8.3664
- PE 6.2038
- Debt/Assets 0.4415
- DivYield 0
- ROE 0.1709
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 1
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ARDT | KeyBanc Capital Markets | Overweight | Sector Weight | -- | -- | Nov. 17, 2025 |
| Downgrade | ARDT | Morgan Stanley | Overweight | Equal Weight | -- | -- | Nov. 14, 2025 |
| Initiation | ARDT | Goldman | -- | Neutral | -- | $19 | Oct. 14, 2025 |
| Initiation | ARDT | UBS | -- | Buy | -- | $17 | Sept. 10, 2025 |
| Downgrade | ARDT | BofA Securities | Neutral | Underperform | -- | $14.6 | July 16, 2025 |
| Resumed | ARDT | JP Morgan | -- | Neutral | -- | $20 | Dec. 17, 2024 |
| Initiation | ARDT | KeyBanc Capital Markets | -- | Overweight | -- | $24 | Oct. 11, 2024 |
News
Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge
Published: November 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues
Read More
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm
Published: November 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman
Published: November 26, 2025 by: PRNewsWire
Sentiment: Neutral
ARDT Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring. The developments and significant market reaction has prompted shareholder rights law firm Hagens Berman to open an investigation into whether Ardent Health may have violated the federal securities laws.
Read More
Ardent Health, Inc. Investigated by the Portnoy Law Firm
Published: November 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ardent Health, Inc., (“Ardent" or the "Company") (NYSE: ARDT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Read More
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring.
Read More
Ardent Health, Inc. (NYSE: ARDT) Investigation Alert: Johnson Fistel Reviews Accounting Adjustment and Liability Reserve Increase Following Stock Drop
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Ardent Health, Inc. (NYSE: ARDT) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors.
Read More
ARDT INVESTORS: BFA Law Reminds Ardent Health, Inc. Investors with Losses to Contact the Firm About its Ongoing Securities Investigation
Published: November 20, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.
Read More
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman
Published: November 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring. The developments and significant market reaction has prompted shareholder rights law firm Hagens Berman to open an investigation into whether Ardent Health may have violated the federal securities laws.
Read More
ARDT INVESTIGATION: Ardent Health, Inc. Investors that Suffered Losses are Notified to Contact BFA Law about the Ongoing Securities Investigation
Published: November 19, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - November 19, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.
Read More
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm
Published: November 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
ARDT SECURITIES NOTICE: BFA Law Alerts Ardent Health, Inc. Investors of the Pending Securities Class Action Investigation and to Contact the Firm for Details
Published: November 18, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.
Read More
New Strong Sell Stocks for Nov. 18th
Published: November 18, 2025 by: Zacks Investment Research
Sentiment: Negative
DIOD, ARDT and FFIV have been added to the Zacks Rank #5 (Strong Sell) List on November 18, 2025.
Read More
Levi & Korsinsky Investigating Whether Ardent Health, Inc. (ARDT) Misled Investors - Securities Law Violations Possible
Published: November 17, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - November 17, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Ardent Health, Inc. ("Ardent Health, Inc.") (NYSE: ARDT) concerning possible violations of federal securities laws. Ardent issued a press release on November 12, 2025, announcing its financial results for the third quarter of 2025.
Read More
ARDT SECURITIES ALERT: BFA Law Notifies Ardent Health, Inc. Investors of Important Securities Class Action Investigation after Stock Plummets 33%
Published: November 17, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - November 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.
Read More
ARDT BREAKING: Ardent Health, Inc. Revenue Drop Triggers Securities Fraud Investigation after Stock Plummets 33% -- Investors Urged to Contact BFA Law
Published: November 13, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $ARDT #ARDT--Ardent Health, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
Read More
Ardent Health, Inc. (ARDT) Q3 2025 Earnings Call Transcript
Published: November 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Ardent Health, Inc. ( ARDT ) Q3 2025 Earnings Call November 13, 2025 9:00 AM EST Company Participants David Styblo - Senior Vice President of Investor Relations Martin Bonick - President, CEO & Director Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Jason Cassorla - Guggenheim Securities, LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Kevin Fischbeck - BofA Securities, Research Division Zach Haggerty Raj Kumar - Stephens Inc., Research Division Craig Hettenbach - Morgan Stanley, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Benjamin …
Read More
Ardent Health, Inc. (NYSE: ARDT) Investigation Alert: Johnson Fistel Reviews Accounting Adjustment and Liability Reserve Increase Following Stock Drop
Published: November 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Ardent Health, Inc. (NYSE: ARDT) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors.
Read More
Ardent Health, Inc. (ARDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Published: September 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Ardent Health, Inc. (NYSE:ARDT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:45 AM EDT Company Participants Martin Bonick - President, CEO & Director Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. Great. Good morning, everyone.
Read More
Ardent Health: The Best Prospect In An Industry That's Facing Challenges
Published: July 17, 2025 by: Seeking Alpha
Sentiment: Negative
Ardent Health faces significant legislative risks, due to Medicaid and Medicare cuts, causing uncertainty and a recent downgrade, but much of this is priced in. Despite headwinds, Ardent Health demonstrates strong revenue and profitability growth, low leverage, and trades at compellingly cheap valuations, versus peers. Management projects continued growth for 2025, with revenue and EBITDA expected to rise, supported by higher-margin service expansions and acquisitions.
Read More
Wall Street Analysts Predict a 36.55% Upside in Ardent Health Partners, Inc. (ARDT): Here's What You Should Know
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Ardent Health Partners, Inc. (ARDT) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
Ardent Health Reports First Quarter 2025 Results
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of.
Read More
Ardent Health Reports Fourth Quarter 2024 Results
Published: February 26, 2025 by: Business Wire
Sentiment: Neutral
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics belo.
Read More
About Ardent Health Partners, LLC (ARDT)
- IPO Date
- Website https://www.ardenthealth.com
- Industry Medical - Care Facilities
- CEO Martin J. Bonick FACHE, M.H.A.
- Employees 19200